×
Miri Halperin Wernli från mindmed.co
Dr. Halperin Wernli was appointed Executive President in February 2021 and has served on our Board of Directors since August 2020. Prior to joining MindMed, Dr. Halperin Wernli co-founded Creso Pharma, a medical cannabis company, and listed the company on the Australian Stock exchange (ASX) in ...
MindMed is a clinical stage biopharmaceutical company developing novel product candidates…
Miri Halperin Wernli från www.businessnews.com.au
Dr Miri Halperin Wernli is a senior pharmaceutical and biomedical executive with over 25 years of strategic and operational leadership in the biopharm.
Miri Halperin Wernli

Miri Halperin Wernli

Miri Halperin Wernli is the founder of Melodiol Global Health Ltd., which was founded in 2015. She held the title of Group CEO, Managing Director ...
Miri Halperin Wernli från theorg.com
Dr. Halperin Wernli is a senior pharmaceutical and biomedical executive with over 30 years of strategic and operational leadership in the biopharmaceutical ...
Miri Wernli is President at Mind Medicine Mindmed Inc. See Miri Wernli's compensation, career history, education, & memberships.
Miri Halperin Wernli is the director & Executive President of Mind Medicine Inc. Other key executives at Mind Medicine Inc include Chief Legal Officer Mark ...
Miri Halperin Wernli is Executive President at MindMed. She attended Stanford Graduate School of Business.